查看购物车
  • Traditional Chinese
  • English
2021-2031 年北美类器官服务市场报告（范围、细分、动态和竞争分析）
市场调查报告书
商品编码
1843395

2021-2031 年北美类器官服务市场报告（范围、细分、动态和竞争分析）

North America Organoids Services Market Report 2021-2031 by Scope, Segmentation, Dynamics, and Competitive Analysis
出版日期: | 出版商: The Insight Partners | 英文 121 Pages | 订单完成后即时交付

价格

北美类器官服务市场预计将大幅成长，到 2031 年将达到约 65.7444 亿美元，高于 2024 年的 16.4088 亿美元，在此期间复合年复合成长率(CAGR) 高达 21.9%。

执行摘要和市场分析

市场分为三个主要区域：美国、加拿大和墨西哥，预计美国将在 2024 年占据主导地位。类器官服务市场成长的主要驱动力包括慢性疾病和病毒感染的盛行率上升、类器官模型的商业化、研发活动的增加以及干细胞研究的进步。

市场区隔分析

北美类器官服务市场可根据类型、应用和来源进行细分：

  • 依类型：市场包括各种类器官类型，如肠、肝、胃、胰臟、肺、脑、肾等。预计肠道类器官将在2024年占据最大的市场份额。
  • 依应用分类：应用分为发育生物学疾病、传染病病理学、再生医学、药物毒性和疗效测试、药物发现和个人化医疗等。预计发育生物学疾病领域将在2024年引领市场。
  • 依来源：市场分为多能干细胞和器官特异性成体干细胞，预计多能干细胞将在 2024 年占据主导地位。

市场展望

类器官正成为研究人员和药物开发者的必备工具，为识别有前景的候选药物并预测其疗效提供了更有效率、更精准的方法。能够创造患者来源的类器官，为个人化药物筛选带来了令人兴奋的机会。与传统的二维细胞培养不同，类器官复製了人体器官的复杂性，包括其细胞组成、结构和功能，从而能够更准确地预测药物反应。这种能力使研究人员能够更有信心地识别潜在的候选药物，从而降低临床试验中代价高昂的失败风险。

由于对创新筛选服务的需求不断增长，类器官服务市场正在快速扩张。透过利用源自患者细胞的类器官，研究人员可以根据个别反应客製化药物测试，从而透过个人化方法提高治疗成功率。高通量筛选和自动化影像分析等先进技术的整合，进一步提升了类器官筛选服务的效能。这种结合使研究人员能够有效地测试多种药物化合物，更准确地分析结果，并加快药物研发进程。个人化医疗的兴起和对更快药物开发的需求推动了全球对创新筛选服务的重视，这推动了北美类器官服务市场的成长。

2024年1月，HUB Organoids推出了IntegriGut Screen，这是一项创新的筛检服务，利用发炎性肠道疾病 (IBD) 患者的类器官单层细胞。该服务提供了高品质的人体上皮屏障功能资料，有助于开发新的IBD疗法。

国家洞察

北美类器官服务市场主要由美国、加拿大和墨西哥组成，其中美国在2024年占据最大市场份额。美国类器官服务市场的公司正专注于有机成长策略，以提升其市场占有率。例如，2023年2月，Molecular Devices, LLC和HUB Organoids宣布建立策略伙伴关係，旨在推动下一代3D生物学技术，从而显着降低从临床前到临床阶段的药物损耗率。

日益增多的研发活动，以及日益增长的组织工程和器官移植需求，正在推动美国类器官服务市场的发展。类器官有望突破生物医学研究中先前面临的诸多限制，例如深入了解人类发育过程、创建精准的疾病模型以及生成用于再生医学的患者匹配组织。研究经费和创投也在推动人类类器官发展方面发挥了至关重要的作用。例如，美国国家科学基金会资助的一个合作计画价值约150万美元，旨在增强脑类器官的发育过程，并提高研究人员最终产品的一致性和可靠性。

公司简介

北美类器官服务市场的关键参与者包括 CUSABIO TECHNOLOGY LLC、Cyprio、Eurofins Scientific SE、HUB Organoids BV、InnoSer、InSphero、LABTOO、Molecular Devices, LLC、Oncodesign Services 和 Sino Biological Inc. 这些公司正在采用扩张、产品创新和併购等各种市场份额来增强其产品。

目录

第一章：简介

第二章：执行摘要

  • 关键见解

第三章：研究方法

  • 二次研究
  • 初步研究
    • 假设表述：
    • 宏观经济因素分析：
    • 显影基数：
    • 数据三角测量：
    • 国家级资料：

第四章：北美类器官服务市场格局

  • PEST分析

第五章：北美类器官服务市场－关键市场动态

  • 北美类器官服务市场－关键市场动态
  • 市场驱动因素
    • 创新药物筛选服务需求不断成长
    • 个人化药物的普及度激增
  • 市场限制
    • 缺乏熟练的专业人员
  • 市场机会
    • 增加关键发展
  • 未来趋势
    • 人工智慧的融合
  • 驱动因素和限制因素的影响：

第六章：北美类器官服务市场 - 分析

  • 2021-2031年北美类器官服务市场收入
  • 北美类器官服务市场预测分析

第七章：北美类器官服务市场分析－依类型

  • 肠
  • 肝
  • 胃
  • 胰臟
  • 肺
  • 脑
  • 肾
  • 其他的

第八章：北美类器官服务市场分析－依应用

  • 发育生物学疾病
  • 传染病病理学
  • 再生医学
  • 药物毒性和疗效测试
  • 药物研发与个人化医疗
  • 其他的

第九章：北美类器官服务市场分析－依来源

  • 多能干细胞
  • 器官特异性成体干细胞

第 10 章：北美类器官服务市场 - 国家分析

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥

第 11 章：产业格局

  • 概述
  • 类器官服务市场的成长策略
  • 有机成长策略
    • 概述
  • 无机成长策略
    • 概述

第 12 章：公司简介

  • Sino Biological Inc.
  • Eurofins Scientific SE
  • Molecular Devices, LLC.
  • InSphero
  • Cyprio
  • InnoSer
  • LABTOO
  • CUSABIO TECHNOLOGY LLC
  • Oncodesign Services
  • HUB Organoids B.V. (Hubrecht Organoid Technology)

第 13 章：附录

Product Code: BMIRE00032023

The North America organoid services market is projected to grow significantly, reaching approximately US$ 6,574.44 million by 2031, up from US$ 1,640.88 million in 2024, reflecting a robust compound annual growth rate (CAGR) of 21.9% during this period.

Executive Summary and Market Analysis

The market is divided into three primary regions: the United States, Canada, and Mexico, with the US anticipated to dominate the market share in 2024. Key drivers of growth in the organoid services market include the rising prevalence of chronic diseases and viral infections, the commercialization of organoid models, increased research and development activities, and advancements in stem cell research.

Market Segmentation Analysis

The North America organoid services market can be segmented based on type, application, and source:

  • By Type: The market includes various organoid types such as intestine, liver, stomach, pancreas, lung, brain, kidney, and others. The intestine segment is expected to hold the largest market share in 2024.
  • By Application: Applications are categorized into developmental biology disease, infectious disease pathology, regenerative medicine, drug toxicity and efficacy testing, drug discovery and personalized medicine, among others. The developmental biology disease segment is projected to lead the market in 2024.
  • By Source: The market is divided into pluripotent stem cells and organ-specific adult stem cells, with pluripotent stem cells expected to dominate in 2024.

Market Outlook

Organoids are becoming essential tools for researchers and pharmaceutical developers, offering more efficient and precise methods for identifying promising drug candidates and predicting their effectiveness. The ability to create patient-derived organoids presents exciting opportunities for personalized drug screening. Unlike traditional 2D cell cultures, organoids replicate the complexity of human organs, including their cellular makeup, structure, and function, which leads to more accurate drug response predictions. This capability allows researchers to identify potential drug candidates with greater confidence, reducing the risk of costly failures in clinical trials.

The organoid services market is experiencing rapid expansion due to the increasing demand for innovative screening services. By utilizing organoids derived from patients' cells, researchers can customize drug testing to individual responses, enhancing the chances of successful treatments through personalized approaches. The integration of advanced technologies, such as high-throughput screening and automated image analysis, further boosts the effectiveness of organoid screening services. This combination allows researchers to efficiently test numerous drug compounds, analyze results with greater accuracy, and expedite the drug discovery process. The global emphasis on innovative screening services, driven by the rise of personalized medicine and the need for faster drug development, supports the growth of the North America organoid services market.

In January 2024, HUB Organoids launched the IntegriGut Screen, a novel screening service that utilizes patient-derived organoid monolayers from inflammatory bowel disease (IBD) patients. This service provides high-quality human data on epithelial barrier function, facilitating the development of new therapies for IBD.

Country Insights

The North America organoid services market is primarily composed of the US, Canada, and Mexico, with the US holding the largest market share in 2024. Companies in the US organoid services market are focusing on organic growth strategies to enhance their market presence. For instance, in February 2023, Molecular Devices, LLC and HUB Organoids announced a strategic partnership aimed at advancing next-generation 3D biology technologies to significantly reduce drug attrition rates from preclinical to clinical stages.

The increasing research and development activities, along with a growing demand for tissue engineering and organ transplantation, are propelling the organoid services market in the US. Organoids have the potential to address several limitations previously faced in biomedical research, such as gaining insights into human development, creating accurate disease models, and generating patient-matched tissues for regenerative medicine. Research funding and venture capital investments have also played a crucial role in advancing human organoid development. For example, a collaborative project funded by the National Science Foundation, valued at approximately US$ 1.5 million, aims to enhance brain organoid development processes and improve the consistency and reliability of end products for researchers.

Company Profiles

Key players in the North America organoid services market include CUSABIO TECHNOLOGY LLC, Cyprio, Eurofins Scientific SE, HUB Organoids B.V., InnoSer, InSphero, LABTOO, Molecular Devices, LLC, Oncodesign Services, and Sino Biological Inc. These companies are employing various strategies such as expansion, product innovation, and mergers and acquisitions to enhance their offerings and increase market share.

Table Of Contents

1. Introduction

  • 1.1 Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Secondary Research
  • 3.2 Primary Research
    • 3.2.1 Hypothesis formulation:
    • 3.2.2 Macro-economic factor analysis:
    • 3.2.3 Developing base number:
    • 3.2.4 Data Triangulation:
    • 3.2.5 Country level data:

4. North America Organoids Services Market Landscape

  • 4.1 PEST Analysis

5. North America Organoids Services Market - Key Market Dynamics

  • 5.1 North America Organoids Services Market - Key Market Dynamics
  • 5.2 Market Drivers
    • 5.2.1 Increasing Demand for Innovative Drug Screening Services
    • 5.2.2 Surge in Popularity of Personalized Drugs
  • 5.3 Market Restraints
    • 5.3.1 Dearth of Skilled Professionals
  • 5.4 Market Opportunities
    • 5.4.1 Increasing Key Developments
  • 5.5 Future Trends
    • 5.5.1 Integration of Artificial Intelligence
  • 5.6 Impact of Drivers and Restraints:

6. North America Organoids Services Market - Analysis

  • 6.1 North America Organoids Services Market Revenue (US$ Million), 2021-2031
  • 6.2 North America Organoids Services Market Forecast Analysis

7. North America Organoids Services Market Analysis - by Type

  • 7.1 Intestine
    • 7.1.1 Overview
    • 7.1.2 Intestine: North America Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.2 Liver
    • 7.2.1 Overview
    • 7.2.2 Liver: North America Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.3 Stomach
    • 7.3.1 Overview
    • 7.3.2 Stomach: North America Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.4 Pancreas
    • 7.4.1 Overview
    • 7.4.2 Pancreas: North America Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.5 Lung
    • 7.5.1 Overview
    • 7.5.2 Lung: North America Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.6 Brain
    • 7.6.1 Overview
    • 7.6.2 Brain: North America Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.7 Kidney
    • 7.7.1 Overview
    • 7.7.2 Kidney: North America Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.8 Others
    • 7.8.1 Overview
    • 7.8.2 Others: North America Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)

8. North America Organoids Services Market Analysis - by Application

  • 8.1 Developmental Biology Disease
    • 8.1.1 Overview
    • 8.1.2 Developmental Biology Disease: North America Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 8.2 Pathology of Infectious Disease
    • 8.2.1 Overview
    • 8.2.2 Pathology of Infectious Disease: North America Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 8.3 Regenerative Medicine
    • 8.3.1 Overview
    • 8.3.2 Regenerative Medicine: North America Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 8.4 Drug Toxicity and Efficacy Testing
    • 8.4.1 Overview
    • 8.4.2 Drug Toxicity and Efficacy Testing: North America Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 8.5 Drug Discovery and Personalized Medicine
    • 8.5.1 Overview
    • 8.5.2 Drug Discovery and Personalized Medicine: North America Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 8.6 Others
    • 8.6.1 Overview
    • 8.6.2 Others: North America Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)

9. North America Organoids Services Market Analysis - by Source

  • 9.1 Pluripotent Stem Cells
    • 9.1.1 Overview
    • 9.1.2 Pluripotent Stem Cells: North America Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 9.2 Organ Specific Adult Stem Cell
    • 9.2.1 Overview
    • 9.2.2 Organ Specific Adult Stem Cell: North America Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)

10. North America Organoids Services Market - Country Analysis

  • 10.1 North America
    • 10.1.1 North America Organoids Services Market - Revenue and Forecast Analysis - by Country
      • 10.1.1.1 North America Organoids Services Market - Revenue and Forecast Analysis - by Country
      • 10.1.1.2 United States: North America Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.1.1.2.1 United States: North America Organoids Services Market Share - by Type
        • 10.1.1.2.2 United States: North America Organoids Services Market Share - by Application
        • 10.1.1.2.3 United States: North America Organoids Services Market Share - by Source
      • 10.1.1.3 Canada: North America Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.1.1.3.1 Canada: North America Organoids Services Market Share - by Type
        • 10.1.1.3.2 Canada: North America Organoids Services Market Share - by Application
        • 10.1.1.3.3 Canada: North America Organoids Services Market Share - by Source
      • 10.1.1.4 Mexico: North America Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.1.1.4.1 Mexico: North America Organoids Services Market Share - by Type
        • 10.1.1.4.2 Mexico: North America Organoids Services Market Share - by Application
        • 10.1.1.4.3 Mexico: North America Organoids Services Market Share - by Source

11. Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in Organoids Services Market
  • 11.3 Organic Growth Strategies
    • 11.3.1 Overview
  • 11.4 Inorganic Growth Strategies
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 Sino Biological Inc.
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Eurofins Scientific SE
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Molecular Devices, LLC.
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 InSphero
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Cyprio
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 InnoSer
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 LABTOO
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 CUSABIO TECHNOLOGY LLC
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 Oncodesign Services
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments
  • 12.10 HUB Organoids B.V. (Hubrecht Organoid Technology)
    • 12.10.1 Key Facts
    • 12.10.2 Business Description
    • 12.10.3 Products and Services
    • 12.10.4 Financial Overview
    • 12.10.5 SWOT Analysis
    • 12.10.6 Key Developments

13. Appendix

  • 13.1 About The Insight Partners
  • 13.2 Glossary of Terms

List Of Tables

  • Table 1. North America Organoids Services Market Segmentation
  • Table 2. North America Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Table 3. North America Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Type
  • Table 4. North America Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Application
  • Table 5. North America Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Source
  • Table 6. North America Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Country
  • Table 7. United States: North America Organoids Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
  • Table 8. United States: North America Organoids Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
  • Table 9. United States: North America Organoids Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Source
  • Table 10. Canada: North America Organoids Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
  • Table 11. Canada: North America Organoids Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
  • Table 12. Canada: North America Organoids Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Source
  • Table 13. Mexico: North America Organoids Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
  • Table 14. Mexico: North America Organoids Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
  • Table 15. Mexico: North America Organoids Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Source
  • Table 16. Recent Organic Growth Strategies in Organoids Services Market
  • Table 17. Recent Inorganic Growth Strategies in the Organoids Services Market
  • Table 18. Glossary of Terms, Organoids Services Market

List Of Figures

  • Figure 1. North America Organoids Services Market Segmentation - Country
  • Figure 2. PEST Analysis
  • Figure 1. Impact Analysis of Drivers and Restraints
  • Figure 2. North America Organoids Services Market Revenue (US$ Million), 2021-2031
  • Figure 3. North America Organoids Services Market Share (%) - by Type (2023 and 2031)
  • Figure 4. Intestine: North America Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 5. Liver: North America Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 6. Stomach: North America Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 7. Pancreas: North America Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 8. Lung: North America Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 9. Brain: North America Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 10. Kidney: North America Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 11. Others: North America Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 12. North America Organoids Services Market Share (%) - by Application (2023 and 2031)
  • Figure 13. Developmental Biology Disease: North America Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 14. Pathology of Infectious Disease: North America Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 15. Regenerative Medicine: North America Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 16. Drug Toxicity and Efficacy Testing: North America Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 17. Drug Discovery and Personalized Medicine: North America Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 18. Others: North America Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 19. North America Organoids Services Market Share (%) - by Source (2023 and 2031)
  • Figure 20. Pluripotent Stem Cells: North America Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 21. Organ Specific Adult Stem Cell: North America Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 22. North America Organoids Services Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 23. United States: North America Organoids Services Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 24. Canada: North America Organoids Services Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 25. Mexico: North America Organoids Services Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 26. Growth Strategies in Organoids Services Market